Rafael S. Rios

1.2k total citations · 1 hit paper
29 papers, 806 citations indexed

About

Rafael S. Rios is a scholar working on Epidemiology, Hepatology and Cell Biology. According to data from OpenAlex, Rafael S. Rios has authored 29 papers receiving a total of 806 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Epidemiology, 12 papers in Hepatology and 5 papers in Cell Biology. Recurrent topics in Rafael S. Rios's work include Liver Disease Diagnosis and Treatment (21 papers), Liver Disease and Transplantation (6 papers) and Liver Diseases and Immunity (5 papers). Rafael S. Rios is often cited by papers focused on Liver Disease Diagnosis and Treatment (21 papers), Liver Disease and Transplantation (6 papers) and Liver Diseases and Immunity (5 papers). Rafael S. Rios collaborates with scholars based in China, Italy and United Kingdom. Rafael S. Rios's co-authors include Ming‐Hua Zheng, Kenneth I. Zheng, Giovanni Targher, Christopher D. Byrne, Wen‐Yue Liu, Gong Feng, Qinqin Yan, Sven Van Poucke, Ting-Yao Wang and Weijie Yuan and has published in prestigious journals such as PLoS ONE, Journal of Hepatology and British Journal Of Nutrition.

In The Last Decade

Rafael S. Rios

27 papers receiving 792 citations

Hit Papers

MAFLD and risk of CKD 2020 2026 2022 2024 2020 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. MAFLD and risk of CKD
    2020 209 citations Dan‐Qin Sun, Yan Jin et al. Metabolism profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rafael S. Rios China 11 496 238 181 179 118 29 806
Mithun Sharma India 21 654 1.3× 324 1.4× 133 0.7× 506 2.8× 112 0.9× 90 1.2k
Jian-Gao Fan China 4 915 1.8× 204 0.9× 383 2.1× 324 1.8× 94 0.8× 5 1.2k
Chiranjeevi Gadiparthi United States 14 486 1.0× 124 0.5× 95 0.5× 335 1.9× 53 0.4× 29 910
Roberta Forlano United Kingdom 14 398 0.8× 104 0.4× 106 0.6× 161 0.9× 23 0.2× 42 634
Dinesh Jothimani India 11 401 0.8× 437 1.8× 47 0.3× 291 1.6× 172 1.5× 54 987
Wen‐Yue Liu China 12 342 0.7× 314 1.3× 82 0.5× 116 0.6× 181 1.5× 22 745
Brian Lam United States 18 1.2k 2.4× 165 0.7× 414 2.3× 753 4.2× 41 0.3× 43 1.4k
Yong‐Ping Chen China 22 1.2k 2.4× 168 0.7× 378 2.1× 557 3.1× 47 0.4× 60 1.5k
Stefan Weiler Switzerland 15 228 0.5× 155 0.7× 42 0.2× 83 0.5× 41 0.3× 71 784
Rosa Martín‐Mateos Spain 14 513 1.0× 111 0.5× 64 0.4× 413 2.3× 20 0.2× 39 923

Countries citing papers authored by Rafael S. Rios

Since Specialization
Citations

This map shows the geographic impact of Rafael S. Rios's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rafael S. Rios with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rafael S. Rios more than expected).

Fields of papers citing papers by Rafael S. Rios

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rafael S. Rios. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rafael S. Rios. The network helps show where Rafael S. Rios may publish in the future.

Co-authorship network of co-authors of Rafael S. Rios

This figure shows the co-authorship network connecting the top 25 collaborators of Rafael S. Rios. A scholar is included among the top collaborators of Rafael S. Rios based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rafael S. Rios. Rafael S. Rios is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Gang, Xiaoling Chi, Jinjun Chen, et al.. (2023). LEARN algorithm: a novel option for predicting non-alcoholic steatohepatitis. HepatoBiliary Surgery and Nutrition. 12(4). 507–522. 3 indexed citations
2.
Feng, Gong, Kenneth I. Zheng, Liang‐Jie Tang, et al.. (2022). Glycemic control predicts the risk of hepatic fibrosis in biopsy-proven NAFLD: a possible mediating role for leukemia inhibitory factor?. PubMed. 1(1). 30–34. 4 indexed citations
3.
Zhang, Huai, Rafael S. Rios, Yangyang Li, et al.. (2022). J-shaped relationship between serum zinc levels and the severity of hepatic necro-inflammation in patients with MAFLD. Nutrition Metabolism and Cardiovascular Diseases. 32(5). 1259–1265. 10 indexed citations
4.
Ma, Hong‐Lei, Kenneth I. Zheng, Rafael S. Rios, et al.. (2021). Histological Characteristics of Non-alcoholic Steatohepatitis in NAFLD Patients With Low Degree of Hepatocyte Apoptosis. The Turkish Journal of Gastroenterology. 32(9). 758–764. 1 indexed citations
5.
6.
7.
Liu, Wen‐Yue, Xiaofang Zhang, Liang‐Jie Tang, et al.. (2021). Protective association of Klotho rs495392 gene polymorphism against hepatic steatosis in non-alcoholic fatty liver disease patients. Clinical and Molecular Hepatology. 28(2). 183–195. 9 indexed citations
8.
Li, Gang, Liang‐Jie Tang, Pei‐Wu Zhu, et al.. (2021). PNPLA3 rs738409 C>G Variant Influences the Association Between Visceral Fat and Significant Fibrosis in Biopsy-proven Nonalcoholic Fatty Liver Disease. Journal of Clinical and Translational Hepatology. 10(3). 439–448. 7 indexed citations
9.
Xu, Ke, Kenneth I. Zheng, Pei‐Wu Zhu, et al.. (2021). Interaction of SAMM50-rs738491 , PARVB-rs5764455 and PNPLA3-rs738409 Increases Susceptibility to Nonalcoholic Steatohepatitis. Journal of Clinical and Translational Hepatology. 10(2). 219–229. 10 indexed citations
10.
Liu, Wen‐Yue, Mohammed Eslam, Kenneth I. Zheng, et al.. (2021). Associations of Hydroxysteroid 17-beta Dehydrogenase 13 Variants with Liver Histology in Chinese Patients with Metabolic-associated Fatty Liver Disease. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 10 indexed citations
11.
Tang, Liang‐Jie, Rafael S. Rios, Huai Zhang, et al.. (2021). Telomerase: a key player in the pathogenesis of non-alcoholic fatty liver disease?. Expert Review of Gastroenterology & Hepatology. 15(7). 811–819. 4 indexed citations
12.
Dinh, An Q, Jinnethe Reyes, Maria Reyes‐Mantilla, et al.. (2020). 28. Regulation of the Staphylococcal β-lactamase Plays a Major Role in the cefazolin Inoculum Effect. Open Forum Infectious Diseases. 7(Supplement_1). S14–S15.
13.
Sun, Dan‐Qin, Yan Jin, Ting-Yao Wang, et al.. (2020). MAFLD and risk of CKD. Metabolism. 115. 154433–154433. 209 indexed citations breakdown →
14.
Rios, Rafael S., Kenneth I. Zheng, & Ming‐Hua Zheng. (2020). Data sharing during COVID-19 pandemic: what to take away. Expert Review of Gastroenterology & Hepatology. 14(12). 1125–1130. 14 indexed citations
15.
Zheng, Kenneth I., Rafael S. Rios, Qiqiang Zeng, & Ming‐Hua Zheng. (2020). COVID-19 Cross-Infection and Pressured Ulceration Among Healthcare Workers: Are We Really Protected by Respirators?. Frontiers in Medicine. 7. 571493–571493. 4 indexed citations
16.
Zheng, Kenneth I., Rafael S. Rios, Gang Li, et al.. (2020). Optimal thresholds for ultrasound attenuation parameter in the evaluation of hepatic steatosis severity: evidence from a cohort of patients with biopsy-proven fatty liver disease. European Journal of Gastroenterology & Hepatology. 33(3). 430–435. 11 indexed citations
17.
Zheng, Kenneth I., Pei‐Wu Zhu, Yangyang Li, et al.. (2020). FNDC5 polymorphism influences the association between sarcopenia and liver fibrosis in adults with biopsy-proven non-alcoholic fatty liver disease. British Journal Of Nutrition. 126(6). 813–824. 13 indexed citations
18.
Feng, Gong, Kenneth I. Zheng, Qinqin Yan, et al.. (2020). COVID-19 and Liver Dysfunction: Current Insights and Emergent Therapeutic Strategies. Journal of Clinical and Translational Hepatology. 8(1). 1–7. 293 indexed citations
19.
Liu, Wen‐Yue, Kenneth I. Zheng, Xiaoyan Pan, et al.. (2019). Effect of PNPLA3 polymorphism on diagnostic performance of various noninvasive markers for diagnosing and staging nonalcoholic fatty liver disease. Journal of Gastroenterology and Hepatology. 35(6). 1057–1064. 24 indexed citations
20.
Rios, Rafael S., et al.. (2013). Are TGF-β gene polymorphisms associated to asthma risk?. 1(1). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mithun Sharma Breakdown of academic impact, for papers by Jian-Gao Fan Breakdown of academic impact, for papers by Chiranjeevi Gadiparthi Breakdown of academic impact, for papers by Roberta Forlano Breakdown of academic impact, for papers by Dinesh Jothimani Breakdown of academic impact, for papers by Wen‐Yue Liu Breakdown of academic impact, for papers by Brian Lam Breakdown of academic impact, for papers by Yong‐Ping Chen Breakdown of academic impact, for papers by Stefan Weiler Breakdown of academic impact, for papers by Rosa Martín‐Mateos
Rankless by CCL
2026